3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
2
OTHER_GOV
1
NIH
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
NET
1
Endocrine
1
Conditions
Thymoma
1
Sarcoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neuroendocrine Tumors
1
Neoplasm Metastasis
1
Mesothelioma
1
Lung Neoplasms
1
Fallopian Tube Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
olaparib
1
copper dotatate CU-64
1
Tomography, Emission-Computed, Single-Photon
1
Positron Emission Tomography Computed Tomography
1
PM 01183
1
Lutetium-177
1
Iodine-124
1
Iodine-123
1
Injections
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Neuroendocrine Tumors
×
olaparib
×
Clear all
NCT04375267
2026-04-14
LuPARP
Vastra Gotaland Region
Phase 1
Completed
18 enrolled